Protecting Our Essential Medicines Act

Hozzl · 2024-12-31T01:53:17Z

Explore the details of Senate Bill 5419 Protecting Our Essential Medicines Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

12/31/2024, 1:53 AM

Summary of Bill S 5419

Bill 118 s 5419, also known as the "Country of Origin of Critical Drugs Act," is a proposed piece of legislation that aims to address concerns about the sourcing of critical drugs in the United States. The bill would require the Secretary of Health and Human Services to create and maintain a list of the country of origin for certain critical drugs that are marketed in the US.

The purpose of this list is to provide transparency and information to consumers, healthcare providers, and policymakers about where these critical drugs are manufactured. This information is seen as important for ensuring the safety and security of the US drug supply chain, as well as for understanding potential vulnerabilities in the event of supply chain disruptions or other emergencies.

In addition to creating the list of country of origin for critical drugs, the bill also includes provisions for the Secretary of Health and Human Services to work with other federal agencies, industry stakeholders, and international partners to address any concerns or issues related to drug sourcing and supply chain security. Overall, the Country of Origin of Critical Drugs Act is aimed at improving transparency and oversight in the pharmaceutical industry, with the goal of ensuring the safety and reliability of critical drugs in the United States.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 5419

Bill S 5419 is currently in the status of Bill Introduced since December 4, 2024. Bill S 5419 was introduced during Congress 118 and was introduced to the Senate on December 4, 2024. Bill S 5419's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of December 4, 2024

Bipartisan Support of Bill S 5419

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 5419

Primary Policy Focus

Alternate Title(s) of Bill S 5419

A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of certain critical drugs marketed in the United States, and for other purposes.A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of certain critical drugs marketed in the United States, and for other purposes.

Start holding our government accountable!

Comments

Sponsors and Cosponsors of S 5419

Tom Cotton

Arkansas(Republican)

Tim Kaine

Virginia(Democrat)

Latest Bills

Authorizing the use of the Capitol Grounds for the National Peace Officers Memorial Service and the National Honor Guard and Pipe Band Exhibition.

Bill HCONRES 9April 12, 2025